BTS
ADAP

BB&T Securities’s Adaptimmune Therapeutics ADAP Stock Holding History

BB&T Securities’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,867
Closed -$128K – 1574
2018
Q2 		$128K Buy
+10,867
New +$128K ﹤0.01% 1485